An interventional study of Smart phone application in Flexor Digitorum Profundus Injury, sponsored by Karolinska Institutet. Completed at 4 sites in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-08-20.
Sponsored by Karolinska Institutet · Not applicable, Interventional, and Treatment
Can a mobile application improve adherence, self-efficacy and range of motion after flexor tendon repair? A randomized controlled multicenter trial.
Aim Evaluate how the use of a mobile application will affect exercise adherence, range of motion and self-efficacy when compared to standard rehabilitation after flexor tendon repair. Method Multicenter randomized controlled trial. Patients with flexor tendon repair in zone I or II were included and rehabilitated with early active motion and followed 12 weeks post-surgery. Randomization was performed by a computer-generated concealed block to control (n=60) or intervention group (n=60). Both groups received standard rehabilitation according to early active motion. Intervention group also received a smart phone app including; exercise videos, push-notifications for exercise, exercise diary, written information on the surgery, rehabilitation, questions and answers. Evaluation was made at baseline, 2, 6- and 12-weeks after surgery. Primary outcome was physiotherapist rated adherence on the Sport Injury Adherence Scale (SIRAS). Secondary outcome was self-reported adherence, perceived self-efficacy, total Active range of motion (TAM) in the Proximal Interphalangeal (PIP) joint and Distal Interphalangeal (DIP) joint and perceived satisfaction with rehabilitation and information.
Karolinska Institutet is the lead sponsor of 1,113 studies on the registry; 267 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Standard treatment
Standard treatment and intervention (Smart phone application)
Other: Smart phone application
Smart phone application including exercise videos, push notifications for exercise, questions and answers, exercise diary.
Sport injury adherence scale (SIRAS)
Physiotherapist rated adherence questionnaire
Time frame: assessed at 2 weeks (totalt score range 3-15, higher value indicates better outcome)
Sport injury adherence scale (SIRAS)
Physiotherapist rated adherence questionnaire
Time frame: assessed at 6 weeks (totalt score range 3-15, higher value indicates better outcome)
Self reported adherence
Patient rated adherence questionnaire duration
Time frame: assessed at 2 and 6 weeks (total score range 0-100,higher value indicates better outcome )
Self reported adherence
Patient rated adherence questionnaire frequency
Time frame: assessed at 2 and 6 weeks (total score range 0-100,higher value indicates better outcome )
Self reported adherence
Patient rated adherence questionnaire quality
Time frame: assessed at 2 and 6 weeks (total score range 0-100, higher value indicates better outcome)
Athlet injury self efficacy questionnaire (AISEQ)
Patient reported self efficacy for rehabilitation
Time frame: baseline, 2 and 6 weeks (Change over time)
Range of motion
Total range of motion in the proximal interphalangeal and distal interphalangeal joints measured with a finger goniometer
Time frame: assessed at 12 weeks (range 0-240,higher value indicates better outcome )
Perceived satisfaction with rehabilitation
questions on a Likert scale regarding satisfaction of rehabilitation. "how do you perceive the rehabilitation after the operation?"
Time frame: at 12 weeks (range 0-100, higher value indicates better outcome)
Perceived satisfaction with information
questions on a Likert scale regarding satisfaction of information: "how do you perceive the information after the operation?"
Time frame: at 12 weeks (range 0-100, higher value indicates better outcome)
This study is completed, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Karolinska Institutet